Skip to main content

Table 1 The clinicopathologic factors of solitary HBV-related HCC patients who underwent initial hepatectomy (n = 1760)

From: Reclassification of tumor size for solitary HBV-related hepatocellular carcinoma by minimum p value method: a large retrospective study

Parameter

Value

Age, years

50.7 ± 10.2

Sex

 

 Male

1497 (85.1%)

 Female

263 (14.9%)

α-Fetoprotein, ng/mL

 

 ≤ 20

726 (41.2%)

 20–400

451 (25.6%)

 ≥ 400

583 (33.1%)

HBV DNA, IU/ml

 

 ≤ 1000

801 (45.5%)

 > 1000

959 (54.5%)

White blood cells, 109/L

5.26 ± 1.74

Platelet count, 109/L

152 (23-479)

Albumin, g/L

41.7 ± 3.74

Total bilirubin, μmol/L

13.4 (3.3–45.4)

γ-Glutamyl transferase, IU/L

55.0 (10–1175)

Alkaline phosphatase, IU/L

80.0 (17–1155)

ALBI grade

 

 ≤ − 2.63

1270 (72.2%)

 > 2.63

490 (27.8%)

Blood loss, mL

 < 800

1650 (93.8%)

 ≥ 800

110 (6.2%)

Tumor size, cm

5.55 ± 3.48

Differentiation degree

 I/II

295 (16.8%)

 III/IV

1465 (83.2%)

Microvascular invasion

 Absent

1354 (76.9%)

 Present

406 (23.1%)

AJCC stage

 

 T1a

121 (6.9%)

 T1b

1250 (71.0%)

 T2

389 (22.1%)

BCLC stage

 

 0

121 (6.9%)

 A

1639 (93.1%)

Tumor capsule

 

 Incomplete/absent

1232 (70.0%)

 Complete

528 (30.0%)

Cirrhosis

 

 Absent

927 (52.7%)

 Present

833 (47.3%)

  1. Values shown are mean ± SD, median (range), or n (%)